Screening and surveillance of multiple solid tumours using plasma placental-like chondroitin sulfate A (pl-CSA)

Placental-like chondroitin sulfate A (pl-CSA) is known to be exclusively synthesized in multiple cancer tissues and associated with disease severity. Here, we aimed to assess whether pl-CSA is released into bio-fluids and can serve as a cancer biomarker.